Annual CAPEX
$77.51 M
+$4.85 M+6.67%
31 December 2023
Summary:
AbCellera Biologics annual capital expenditures is currently $77.51 million, with the most recent change of +$4.85 million (+6.67%) on 31 December 2023. During the last 3 years, it has risen by +$62.83 million (+428.23%). ABCL annual CAPEX is now at all-time high.ABCL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$18.52 M
-$1.59 M-7.93%
30 September 2024
Summary:
AbCellera Biologics quarterly capital expenditures is currently $18.52 million, with the most recent change of -$1.59 million (-7.93%) on 30 September 2024. Over the past year, it has dropped by -$1.81 million (-8.93%). ABCL quarterly CAPEX is now -49.69% below its all-time high of $36.80 million, reached on 30 June 2021.ABCL Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$77.76 M
-$1.81 M-2.28%
30 September 2024
Summary:
AbCellera Biologics TTM capital expenditures is currently $77.76 million, with the most recent change of -$1.81 million (-2.28%) on 30 September 2024. Over the past year, it has increased by +$2.91 million (+3.89%). ABCL TTM CAPEX is now -10.28% below its all-time high of $86.66 million, reached on 31 March 2024.ABCL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABCL CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.7% | -8.9% | +3.9% |
| 3 y3 years | +428.2% | +116.0% | +53.9% |
| 5 y5 years | +1360.5% | - | - |
ABCL CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +428.2% | -40.9% | +116.0% | -10.3% | +53.9% |
| 5 y | 5 years | at high | +1839.1% | -49.7% | +1132.8% | -10.3% | +1292.8% |
| alltime | all time | at high | +1839.1% | -49.7% | +1132.8% | -10.3% | +1292.8% |
AbCellera Biologics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $18.52 M(-7.9%) | $77.76 M(-2.3%) |
| June 2024 | - | $20.11 M(-16.7%) | $79.57 M(-8.2%) |
| Mar 2024 | - | $24.14 M(+61.0%) | $86.66 M(+11.8%) |
| Dec 2023 | $77.51 M(+6.7%) | $14.99 M(-26.3%) | $77.51 M(+3.6%) |
| Sept 2023 | - | $20.33 M(-25.3%) | $74.85 M(+8.4%) |
| June 2023 | - | $27.20 M(+81.5%) | $69.03 M(-5.6%) |
| Mar 2023 | - | $14.98 M(+21.5%) | $73.15 M(+0.7%) |
| Dec 2022 | $72.66 M | $12.33 M(-15.0%) | $72.66 M(+4.2%) |
| Sept 2022 | - | $14.51 M(-53.7%) | $69.76 M(+9.3%) |
| June 2022 | - | $31.32 M(+116.1%) | $63.82 M(-7.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $14.49 M(+53.7%) | $69.30 M(+18.6%) |
| Dec 2021 | $58.45 M(+298.4%) | $9.43 M(+10.0%) | $58.45 M(+15.7%) |
| Sept 2021 | - | $8.57 M(-76.7%) | $50.52 M(+10.2%) |
| June 2021 | - | $36.80 M(+910.0%) | $45.84 M(+259.9%) |
| Mar 2021 | - | $3.64 M(+142.6%) | $12.73 M(-13.2%) |
| Dec 2020 | $14.67 M(+267.1%) | $1.50 M(-61.3%) | $14.67 M(+11.4%) |
| Sept 2020 | - | $3.88 M(+4.9%) | $13.17 M(+41.8%) |
| June 2020 | - | $3.70 M(-33.7%) | $9.29 M(+66.3%) |
| Mar 2020 | - | $5.58 M | $5.58 M |
| Dec 2019 | $4.00 M(-24.7%) | - | - |
| Dec 2018 | $5.31 M | - | - |
FAQ
- What is AbCellera Biologics annual capital expenditures?
- What is the all time high annual CAPEX for AbCellera Biologics?
- What is AbCellera Biologics annual CAPEX year-on-year change?
- What is AbCellera Biologics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for AbCellera Biologics?
- What is AbCellera Biologics quarterly CAPEX year-on-year change?
- What is AbCellera Biologics TTM capital expenditures?
- What is the all time high TTM CAPEX for AbCellera Biologics?
- What is AbCellera Biologics TTM CAPEX year-on-year change?
What is AbCellera Biologics annual capital expenditures?
The current annual CAPEX of ABCL is $77.51 M
What is the all time high annual CAPEX for AbCellera Biologics?
AbCellera Biologics all-time high annual capital expenditures is $77.51 M
What is AbCellera Biologics annual CAPEX year-on-year change?
Over the past year, ABCL annual capital expenditures has changed by +$4.85 M (+6.67%)
What is AbCellera Biologics quarterly capital expenditures?
The current quarterly CAPEX of ABCL is $18.52 M
What is the all time high quarterly CAPEX for AbCellera Biologics?
AbCellera Biologics all-time high quarterly capital expenditures is $36.80 M
What is AbCellera Biologics quarterly CAPEX year-on-year change?
Over the past year, ABCL quarterly capital expenditures has changed by -$1.81 M (-8.93%)
What is AbCellera Biologics TTM capital expenditures?
The current TTM CAPEX of ABCL is $77.76 M
What is the all time high TTM CAPEX for AbCellera Biologics?
AbCellera Biologics all-time high TTM capital expenditures is $86.66 M
What is AbCellera Biologics TTM CAPEX year-on-year change?
Over the past year, ABCL TTM capital expenditures has changed by +$2.91 M (+3.89%)